4-anilinoquinoline-3-carboxamides as CSF-1R kinase inhibitors

Details for Australian Patent Application No. 2007238372 (hide)

Owner AstraZeneca AB

Inventors Cook, Donald; Scott, David; Zheng, Xiaolan; Gero, Thomas; Dakin, Leslie; Del Valle, David

Agent Davies Collison Cave

Pub. Number AU-A-2007238372

PCT Pub. Number WO2007/119046

Priority 60/865,090 09.11.06 US; 60/744,857 14.04.06 US

Filing date 12 April 2007

Wipo publication date 25 October 2007

International Classifications

C07D 215/54 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/119046 Priority application(s): WO2007/119046

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007238386-Method, composition and use

2007238353-Apparatus for use in operator training with, and the testing and evaluation of, infrared sensors which are for missile detection